HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.

Abstract
Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog, is among the most potent and broad-spectrum angiogenesis inhibitors. However, a major clinical limitation is its poor oral availability and short half-life, necessitating frequent, continuous parenteral administration. We have addressed these issues and report an oral formulation of TNP-470, named Lodamin. TNP-470 was conjugated to monomethoxy-polyethylene glycol-polylactic acid to form nanopolymeric micelles. This conjugate can be absorbed by the intestine and selectively accumulates in tumors. Lodamin significantly inhibits tumor growth, without causing neurological impairment in tumor-bearing mice. Using the oral route of administration, it first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice. We show that Lodamin is an oral nontoxic antiangiogenic drug that can be chronically administered for cancer therapy or metastasis prevention.
AuthorsOfra Benny, Ofer Fainaru, Avner Adini, Flavia Cassiola, Lauren Bazinet, Irit Adini, Elke Pravda, Yaakov Nahmias, Samir Koirala, Gabriel Corfas, Robert J D'Amato, Judah Folkman
JournalNature biotechnology (Nat Biotechnol) Vol. 26 Issue 7 Pg. 799-807 (Jul 2008) ISSN: 1546-1696 [Electronic] United States
PMID18587385 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Cyclohexanes
  • Polyesters
  • Sesquiterpenes
  • lodamin
  • O-(Chloroacetylcarbamoyl)fumagillol
Topics
  • Administration, Oral
  • Angiogenesis Inhibitors (administration & dosage)
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Cell Line, Tumor
  • Cyclohexanes (administration & dosage)
  • Humans
  • Lung Neoplasms (blood supply, drug therapy)
  • Mice
  • Neovascularization, Pathologic (drug therapy)
  • O-(Chloroacetylcarbamoyl)fumagillol
  • Polyesters (administration & dosage)
  • Sesquiterpenes (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: